Приказ основних података о документу

dc.creatorde Gonzalo-Calvo, David
dc.creatorSopić, Miron
dc.creatorDevaux, Yvan
dc.date.accessioned2022-12-27T16:01:56Z
dc.date.available2022-12-27T16:01:56Z
dc.date.issued2022
dc.identifier.issn1471-4914
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4362
dc.description.abstractIn the past decade, significant resources have been invested in long noncoding RNA (lncRNA) research. Despite the knowledge available, we are far from incorporation of lncRNA into clinical practice. Here, we emphasize the technical challenges in the field, hoping to provoke a response leading to new consensus and guidelines.
dc.publisherElsevier B.V.
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.relationEuropean Cooperation in Science and Technology (COST)
dc.relationInstituto de Salud Carlos III (Miguel Servet 2020: CP20/00041)
dc.relationnstituto de Salud Carlos III. Y.D. is funded by the EU Horizon 2020 project COVIRNA (Grant Agreement 101016072)
dc.relationNational Research Fund (grants C14/ BM/8225223, C17/BM/11613033, and COVID-19/ 2020-1/14719577/miRCOVID)
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceTrends in Molecular Medicine
dc.subjectbiomarker
dc.subjectlong noncoding RNA
dc.subjectmethods
dc.subjectRT-qPCR
dc.titleMethodological considerations for circulating long noncoding RNA quantification
dc.typecontributionToPeriodical
dc.rights.licenseBY
dc.citation.volume28
dc.citation.issue8
dc.citation.spage616
dc.citation.epage618
dc.identifier.wos000843361300002
dc.identifier.doi10.1016/j.molmed.2022.05.011
dc.identifier.scopus2-s2.0-85131834578
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/11348/Methodological_considerations_for_pub_2022.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу